MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Petros Pharmaceuticals, Inc. (PTPI)

Petros Pharmaceuticals, Inc. (PTPI)

|||

Balance Sheets Overview

Current Ratio
124.64%
Quick Ratio
124.64%
Cash Ratio
122.63%
Debt to Asset Ratio
80.23%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued series a convertible red...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
3,488,595
4,352,450
5,136,722
6,070,266
Prepaid expenses and other current assets
57,124
42,000
26,876
63,202
Total current assets
3,545,719
4,394,450
5,163,598
6,133,468
Total assets
3,545,719
4,394,450
5,163,598
6,133,468
Accounts payable
97,282
133,304
83,883
421,142
Accrued expenses
216,544
190,634
142,486
512,029
Accrued series a convertible redeemable preferred payments payable
2,530,999
2,298,297
2,065,475
1,829,610
Warrant liability
-
900
900
2,600
Total current liabilities
2,844,825
2,623,135
2,292,744
2,765,381
Total liabilities
2,844,825
2,623,135
2,292,744
2,765,381
Common stock (par value 0.0001 per share, 7,000,000,000 and 250,000,000 shares authorized at june 30, 2026, and december 31, 2025, respectively 42,372,502 and 42,284,502 issued and outstanding as of june 30, 2026, and december 31, 2025, respectively)
4,237
4,237
4,228
4,228
Additional paid-in capital
113,934,094
114,048,890
114,161,402
114,322,129
Accumulated deficit
-113,237,437
-112,281,812
-111,294,776
-110,958,270
Total stockholders' equity
700,894
1,771,315
2,870,854
3,368,087
Total liabilities, temporary equity and stockholders' equity
3,545,719
4,394,450
5,163,598
6,133,468
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$3,488,595 (-52.35%↓ Y/Y)Prepaid expenses andother current assets$57,124 (-24.18%↓ Y/Y)Total current assets$3,545,719 (-52.06%↓ Y/Y)Total assets$3,545,719 (-52.06%↓ Y/Y)Total liabilities,temporary equity and...$3,545,719 (-52.06%↓ Y/Y)Total liabilities$2,844,825 (-3.56%↓ Y/Y)Total stockholders'equity$700,894 (-84.24%↓ Y/Y)Accumulated deficit-$113,237,437 (-2.91%↓ Y/Y)Total currentliabilities$2,844,825 (-3.56%↓ Y/Y)Additional paid-in capital$113,934,094 (-0.48%↓ Y/Y)Common stock (par value0.0001 per share,...$4,237 (0.21%↑ Y/Y)Accrued series aconvertible redeemable...$2,530,999 (47.52%↑ Y/Y)Accrued expenses$216,544 (-16.91%↓ Y/Y)Accounts payable$97,282 (-89.97%↓ Y/Y)